Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP327172.RAhRrzUegeaAYikZslQP9Zhk_M7UiGwIDeaaORqmFIxWk130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP327172.RAhRrzUegeaAYikZslQP9Zhk_M7UiGwIDeaaORqmFIxWk130_assertion type Assertion NP327172.RAhRrzUegeaAYikZslQP9Zhk_M7UiGwIDeaaORqmFIxWk130_head.
- NP327172.RAhRrzUegeaAYikZslQP9Zhk_M7UiGwIDeaaORqmFIxWk130_assertion description "[The engineered CD4(+) T cells and CD8(+) T cells both exhibited specific cytotoxicity against CD19(+) leukemia and lymphoma cell lines, as well as against CD19 transfectants, and produced high-levels of antigen-dependent Th1 (but not Th2) cytokines.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP327172.RAhRrzUegeaAYikZslQP9Zhk_M7UiGwIDeaaORqmFIxWk130_provenance.
- NP327172.RAhRrzUegeaAYikZslQP9Zhk_M7UiGwIDeaaORqmFIxWk130_assertion evidence source_evidence_literature NP327172.RAhRrzUegeaAYikZslQP9Zhk_M7UiGwIDeaaORqmFIxWk130_provenance.
- NP327172.RAhRrzUegeaAYikZslQP9Zhk_M7UiGwIDeaaORqmFIxWk130_assertion SIO_000772 18227839 NP327172.RAhRrzUegeaAYikZslQP9Zhk_M7UiGwIDeaaORqmFIxWk130_provenance.
- NP327172.RAhRrzUegeaAYikZslQP9Zhk_M7UiGwIDeaaORqmFIxWk130_assertion wasDerivedFrom befree-20140225 NP327172.RAhRrzUegeaAYikZslQP9Zhk_M7UiGwIDeaaORqmFIxWk130_provenance.
- NP327172.RAhRrzUegeaAYikZslQP9Zhk_M7UiGwIDeaaORqmFIxWk130_assertion wasGeneratedBy ECO_0000203 NP327172.RAhRrzUegeaAYikZslQP9Zhk_M7UiGwIDeaaORqmFIxWk130_provenance.